The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Historical Perspective: Models of Parkinson’s Disease
Open accessAbstract
Parkinson’s disease (PD) is the most common movement disorder with motor and nonmotor signs. The current therapeutic regimen for PD is mainly symptomatic as the etio-pathophysiology has not been fully elucidated. A variety of animal models has been generated to study different aspects of the disease for understanding the pathogenesis and therapeutic development. The disease model can be generated through neurotoxin-based or genetic-based approaches in a wide range of animals such as non-human primates (NHP), rodents, zebrafish, Caenorhabditis (C.) elegans, and drosophila. Cellular-based disease model is frequently used because of the ease of manipulation and suitability for large-screen assays. In neurotoxin-induced models, chemicals such as 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), rotenone, and paraquat are used to recapitulate the disease. Genetic manipulation of PD-related genes, such as α-Synuclein(SNCA), Leucine-rich repeat kinase 2 (LRRK2), Pten-Induced Kinase 1 (PINK1), Parkin(PRKN), and Protein deglycase (DJ-1) Are used in the transgenic models. An emerging model that combines both genetic- and neurotoxin-based methods has been generated to study the role of the immune system in the pathogenesis of PD. Here, we discuss the advantages and limitations of the different PD models and their utility for different research purposes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
The structure of the nervous system of the nematode Caenorhabditis elegans
White, J. G., Southgate, E., Thomson, J. N., & Brenner, S. (1986) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1986.0056 · Cited by 5,589 · cited 1×
“elegans is a 959-cell nematomorph that has a simple nervous network comprising 302 neurons and a dopaminergic network with exactly 8 neurons [20].”
BackgroundPoewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
Jo, J., Xiao, Y., Sun, A. X., Cukuroglu, E., Tran, H.-D., Göke, J., Tan, Z. Y., Saw, T. Y., Tan, C.-P., Lokman, H., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.07.005 · Cited by 861
Self-citationGenetic Animal Models of Parkinson's Disease
Dawson, T. M., Ko, H. S., & Dawson, V. L. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.034 · Cited by 823
Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTP
Schober, A. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0938-y · Cited by 803
Sauer, H., & Oertel, W. H. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90605-x · Cited by 803
LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress
Nguyen, H. N., Byers, B., Cord, B., Shcheglovitov, A., Byrne, J., Gujar, P., Kee, K., Schüle, B., Dolmetsch, R. E., Langston, W., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.01.013 · Cited by 745
Missing pieces in the Parkinson's disease puzzle
Obeso, J. A., Rodriguez-Oroz, M. C., Goetz, C. G., Marin, C., Kordower, J. H., Rodriguez, M., Hirsch, E. C., Farrer, M., Schapira, A. H. V., & Halliday, G. (2010) · Nature Medicine · doi:10.1038/nm.2165 · Cited by 734
The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice
Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L., & Di Monte, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100560200 · Cited by 684
Phillips, K. A., Bales, K. L., Capitanio, J. P., Conley, A., Czoty, P. W., ‘t Hart, B. A., Hopkins, W. D., Hu, S., Miller, L. A., Nader, M. A., et al. (2014) · American Journal of Primatology · doi:10.1002/ajp.22281 · Cited by 612
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Li, Y., Liu, W., Oo, T. F., Wang, L., Tang, Y., Jackson-Lewis, V., Zhou, C., Geghman, K., Bogdanov, M., Przedborski, S., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2349 · Cited by 536
Can, A., Dao, D. T., Terrillion, C. E., Piantadosi, S. C., Bhat, S., & Gould, T. D. (2011) · Journal of Visualized Experiments · doi:10.3791/3769 · Cited by 526
The Rodent Forced Swim Test Measures Stress-Coping Strategy, Not Depression-like Behavior
Commons, K. G., Cholanians, A. B., Babb, J. A., & Ehlinger, D. G. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00042 · Cited by 525
Generation of human brain region–specific organoids using a miniaturized spinning bioreactor
Qian, X., Jacob, F., Song, M. M., Nguyen, H. N., Song, H., & Ming, G.-L. (2018) · Nature Protocols · doi:10.1038/nprot.2017.152 · Cited by 514
Parkinson’s disease induced pluripotent stem cells with triplication of the α-synuclein locus
Devine, M. J., Ryten, M., Vodicka, P., Thomson, A. J., Burdon, T., Houlden, H., Cavaleri, F., Nagano, M., Drummond, N. J., Taanman, J.-W., et al. (2011) · Nature Communications · doi:10.1038/ncomms1453 · Cited by 486
A Guide to Neurotoxic Animal Models of Parkinson's Disease
Tieu, K. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009316 · Cited by 483
Behavioral phenotyping of the MPTP mouse model of Parkinson's disease
Sedelis, M., Schwarting, R. K. W., & Huston, J. P. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00309-6 · Cited by 432
Gispert, S., Ricciardi, F., Kurz, A., Azizov, M., Hoepken, H.-H., Becker, D., Voos, W., Leuner, K., Müller, W. E., Kudin, A. P., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005777 · Cited by 381
Neuroprotective Function of DJ-1 in Parkinson’s Disease
Ariga, H., Takahashi-Niki, K., Kato, I., Maita, H., Niki, T., & Iguchi-Ariga, S. M. M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/683920 · Cited by 373
Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids
Kim, H., Park, H. J., Choi, H., Chang, Y., Park, H., Shin, J., Kim, J., Lengner, C. J., Lee, Y. K., & Kim, J. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.01.020 · Cited by 346
LRRK2 kinase in Parkinson's disease
Alessi, D. R., & Sammler, E. (2018) · Science · doi:10.1126/science.aar5683 · Cited by 345
C-terminal calcium binding of α-synuclein modulates synaptic vesicle interaction
Lautenschläger, J., Stephens, A. D., Fusco, G., Ströhl, F., Curry, N., Zacharopoulou, M., Michel, C. H., Laine, R., Nespovitaya, N., Fantham, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03111-4 · Cited by 334
Petroske, E., Meredith, G. E., Callen, S., Totterdell, S., & Lau, Y.-S. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00295-0 · Cited by 331
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Lee, B. D., Shin, J.-H., VanKampen, J., Petrucelli, L., West, A. B., Ko, H. S., Lee, Y.-I., Maguire-Zeiss, K. A., Bowers, W. J., Federoff, H. J., et al. (2010) · Nature Medicine · doi:10.1038/nm.2199 · Cited by 329
Heikkila, R. E., Nicklas, W. J., Vyas, I., & Duvoisin, R. C. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90580-4 · Cited by 300
Molecular pathogenesis of Parkinson disease: insights from genetic studies
Gasser, T. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001148 · Cited by 290
Matsuoka, Y., Vila, M., Lincoln, S., McCormack, A., Picciano, M., LaFrancois, J., Yu, X., Dickson, D., Langston, W. J., McGowan, E., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0392 · Cited by 281
Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment
Zeng, X.-S., Geng, W.-S., & Jia, J.-J. (2018) · ASN Neuro · doi:10.1177/1759091418777438 · Cited by 275
Clark, D. G., McElligott, T. F., & Hurst, E. W. (1966) · Occupational and Environmental Medicine · doi:10.1136/oem.23.2.126 · Cited by 263
Absence of nigral degeneration in aged parkin/DJ‐1/PINK1 triple knockout mice
Kitada, T., Tong, Y., Gautier, C. A., & Shen, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06350.x · Cited by 261
Age-dependent Motor Deficits and Dopaminergic Dysfunction in DJ-1 Null Mice
Chen, L., Cagniard, B., Mathews, T., Jones, S., Koh, H. C., Ding, Y., Carvey, P. M., Ling, Z., Kang, U. J., & Zhuang, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413955200 · Cited by 261
Behavioral models of Parkinson's disease in rodents: A new look at an old problem
Meredith, G. E., & Kang, U. J. (2006) · Movement Disorders · doi:10.1002/mds.21010 · Cited by 250
Genetic risk factors in Parkinson’s disease
Billingsley, K. J., Bandres-Ciga, S., Saez-Atienzar, S., & Singleton, A. B. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2817-y · Cited by 249
Stacy, M., Bowron, A., Guttman, M., Hauser, R., Hughes, K., Larsen, J. P., LeWitt, P., Oertel, W., Quinn, N., Sethi, K., et al. (2005) · Movement Disorders · doi:10.1002/mds.20383 · Cited by 246
A 6-hydroxydopamine-induced selective parkinsonian rat model
Perese, D. A., Ulman, J., Viola, J., Ewing, S. E., & Bankiewicz, K. S. (1989) · Brain Research · doi:10.1016/0006-8993(89)90597-0 · Cited by 241
Absence of MPTP-Induced Neuronal Death in Mice Lacking the Dopamine Transporter
Bezard, E., Gross, C. E., Fournier, M.-C., Dovero, S., Bloch, B., & Jaber, M. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6995 · Cited by 230
Modeling Parkinson’s Disease in C. elegans
Cooper, J. F., & Van Raamsdonk, J. M. (2018) · Journal of Parkinson’s Disease · doi:10.3233/jpd-171258 · Cited by 218
Behavioral phenotyping of mouse models of Parkinson's disease
Taylor, T. N., Greene, J. G., & Miller, G. W. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.03.004 · Cited by 199
Nonhuman Primate Models of Parkinson's Disease
Emborg, M. E. (2007) · ILAR Journal · doi:10.1093/ilar.48.4.339 · Cited by 190
Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease
West, A. B. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.07.019 · Cited by 176
Parkinson’s disease: genetic versus toxin‐induced rodent models
Terzioglu, M., & Galter, D. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06302.x · Cited by 173
DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway
Aleyasin, H., Rousseaux, M. W. C., Marcogliese, P. C., Hewitt, S. J., Irrcher, I., Joselin, A. P., Parsanejad, M., Kim, R. H., Rizzu, P., Callaghan, S. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914876107 · Cited by 168
Vaz, R. L., Outeiro, T. F., & Ferreira, J. J. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00347 · Cited by 166
Sleep disorders in Parkinson's disease: The contribution of the MPTP non-human primate model
Barraud, Q., Lambrecq, V., Forni, C., McGuire, S., Hill, M. P., Bioulac, B. H., Balzamo, E., Bézard, E., Tison, F., & Ghorayeb, I. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.019 · Cited by 164
Dopamine Dynamics and Signaling in Drosophila: An Overview of Genes, Drugs and Behavioral Paradigms
Yamamoto, S., & Seto, E. S. (2014) · Experimental Animals · doi:10.1538/expanim.63.107 · Cited by 163
Imbert, C., Bézard, E., Guitraud, S., Boraud, T., & Gross, C. E. (2000) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(99)00184-3 · Cited by 163
Peng, J., Peng, L., Stevenson, F. F., Doctrow, S. R., & Andersen, J. K. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1569-07.2007 · Cited by 158
Tóth, G., Gardai, S. J., Zago, W., Bertoncini, C. W., Cremades, N., Roy, S. L., Tambe, M. A., Rochet, J.-C., Galvagnion, C., Skibinski, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087133 · Cited by 151
Ossowska, K., Wardas, J., Śmiałowska, M., Kuter, K. Z., Lenda, T., Wierońska, J. M., Zieba, B. A., Nowak, P. G., Dąbrowska, J., Bortel, A. B., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04301.x · Cited by 149
Inden, M., Kitamura, Y., Abe, M., Tamaki, A., Takata, K., & Taniguchi, T. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.92 · Cited by 149
Niso‐Santano, M., González‐Polo, R. A., Pedro, J. M. B., Gómez‐Sánchez, R., Lastres‐Becker, I., Ortiz‐Ortiz, M. A., Soler, G., Morán, J. M., Cuadrado, A., & Fuentes, J. M. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.02.024 · Cited by 140
Ungerstedt, U., Ljungberg, T., & Steg, G. (1974) · PubMed · Cited by 138
Beyond the mitochondrion: cytosolic PINK 1 remodels dendrites through Protein Kinase A
Dagda, R. K., Pien, I., Wang, R., Zhu, J., Wang, K. Z. Q., Callio, J., Banerjee, T. D., Dagda, R. Y., & Chu, C. T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12494 · Cited by 135
Barbeau, A., Dallaire, L., Buu, N. T., Poirier, J., & Rucinska, E. J. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90185-7 · Cited by 119
Song, P., Li, S., Wu, H., Gao, R., Rao, G., Wang, D., Chen, Z., Ma, B., Wang, H., Sui, N., et al. (2016) · Protein & Cell · doi:10.1007/s13238-015-0230-9 · Cited by 117
TRAP1 rescues PINK1 loss-of-function phenotypes
Zhang, L., Karsten, P., Hamm, S., Pogson, J. H., Müller-Rischart, A. K., Exner, N., Haass, C., Whitworth, A. J., Winklhofer, K. F., Schulz, J. B., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt132 · Cited by 111
Haleagrahara, N., Siew, C. J., & Ponnusamy, K. (2013) · The Journal of Toxicological Sciences · doi:10.2131/jts.38.25 · Cited by 110
No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism
Halliday, G. M., Herrero, M. T., Murphy, K., McCann, H., Ros‐Bernal, F., Barcia, C., Mori, H., Blesa, F. J., & Obeso, J. A. (2009) · Movement Disorders · doi:10.1002/mds.22481 · Cited by 108
Function and Characteristics of PINK1 in Mitochondria
Matsuda, S., Kitagishi, Y., & Kobayashi, M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/601587 · Cited by 102
Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model
Tapias, V., Cannon, J. R., & Greenamyre, J. T. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22201 · Cited by 97
Grow, D. A., McCarrey, J. R., & Navara, C. S. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.08.013 · Cited by 95
End-of-dose Wearing Off in Parkinson Disease: A 9-Question Survey Assessment
Stacy, M. A., Hauser, R. A., Oertel, W. H., Schapira, A. H. V., Sethi, K. D., Stocchi, F., & TOLOSA, E. S. (2006) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000232277.68501.08 · Cited by 90
Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson’s Disease
Chlebanowska, P., Tejchman, A., Sułkowski, M., Skrzypek, K., & Majka, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030694 · Cited by 86
Bian, M., Liu, J., Hong, X., Yu, M., Huang, Y., Sheng, Z., Fei, J., & Huang, F. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039953 · Cited by 85
Xu, J., Wei, X., Ren, M., Wang, L., Zhang, X., & Lou, H. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1751-6 · Cited by 75
Brucale, M., Sandal, M., Maio, S. D., Rampioni, A., Tessari, I., Tosatto, L., Bisaglia, M., Bubacco, L., & Samorì, B. (2008) · ChemBioChem · doi:10.1002/cbic.200800581 · Cited by 74
C. elegans as a model system to accelerate discovery for Parkinson disease
Martinez, B., Caldwell, K. A., & Caldwell, G. A. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.02.011 · Cited by 74
Neurotoxicity of the Pesticide Rotenone on Neuronal Polarization: A Mechanistic Approach
Bisbal, M., & Sanchez, M. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.249847 · Cited by 71
Peng, J., Liu, Q., Rao, M. S., & Zeng, X. (2013) · SLAS Discovery · doi:10.1177/1087057112474468 · Cited by 64
Schaeffer, E., Pilotto, A., & Berg, D. (2014) · CNS Drugs · doi:10.1007/s40263-014-0205-z · Cited by 59
Machado, A., Herrera, A. J., Venero, J. L., Santiago, M., de Pablos, R. M., Villarán, R. F., Espinosa‐Oliva, A. M., Argüelles, S., Soto, M. S., Delgado‐Cortés, M. J., et al. (2011) · ISRN Neurology · doi:10.5402/2011/476158 · Cited by 54
A mutation in Drosophila methuselah resists paraquat induced Parkinson-like phenotypes
Shukla, A. K., Pragya, P., Chaouhan, H. S., Patel, D. K., Abdin, M. Z., & Chowdhuri, D. K. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.008 · Cited by 52
Sanchez, G. M., Varaschin, R. K., Büeler, H., Marcogliese, P. C., Park, D. S., & Trudeau, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094826 · Cited by 48
Two new test methods to quantify motor deficits in a marmoset model for Parkinson's disease
Verhave, P. S., Vanwersch, R. A. P., van Helden, H. P. M., Smit, A. B., & Philippens, I. H. C. H. M. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.01.022 · Cited by 47
Martí, Y., Matthäus, F., Lau, T., & Schloss, P. D. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.06.009 · Cited by 35
Sayre, L. M., Wang, F., & Hoppel, C. L. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92672-7 · Cited by 34
ThePolgMutator Phenotype Does Not Cause Dopaminergic Neurodegeneration inDJ-1-Deficient Mice
Hauser, D. N., Primiani, C. T., Langston, R. G., Kumaran, R., & Cookson, M. (2015) · eNeuro · doi:10.1523/eneuro.0075-14.2015 · Cited by 28
Prasad, K., Tarasewicz, E., Ohman‐Strickland, P., O’Neill, M. J., Mitchell, S. N., Merchant, K., Tep, S., Hilton, K., Datwani, A., Buttini, M., et al. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07558.x · Cited by 24
Cited by
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
Zhao, Z., Ning, J., Bao, X.-Q., Shang, M., Ma, J., Li, G., & Zhang, D. (2021) · Microbiome · doi:10.1186/s40168-021-01107-9 · Cited by 616
Mitochondria: It is all about energy
Casanova, A., Wevers, A., Navarro-Ledesma, S., & Pruimboom, L. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1114231 · Cited by 303
Zhao, Z., Li, F., Ning, J., Peng, R., Shang, J., Liu, H., Shang, M., Bao, X.-Q., & Zhang, D. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.020 · Cited by 137
Replacing Animal Testing with Stem Cell-Organoids : Advantages and Limitations
Park, G., Rim, Y. A., Sohn, Y., Nam, Y., & Ju, J. H. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10723-5 · Cited by 92
Metadata
- Authors
- Chia, S. J., Tan, E.-K., & Chao, Y.-X.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-04-02
- Volume
- 21
- Issue
- 7
- Pages
- 2464
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3015095871
- Cited by
- 401
- References
- 90
- FWCI
- 19.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.